Annual review of transplant: kidney transplant 2012.

Ty B Dunn, Arthur J. Matas

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


This chapter highlights contributions to the body of knowledge in kidney transplant for 2012. Specifically, we focus on new developments in alloantibody and chronic allograft injury research. Also, we discuss new immunosuppressant agent trial results. One important new immunosuppressant we cover is belatacept, the first new FDA approved immunosuppressant in many years. Finally, we discuss some key peripheral studies that made 2012 an exciting year in kidney transplant research.

Original languageEnglish (US)
Pages (from-to)167-172
Number of pages6
JournalUnknown Journal
StatePublished - 2012


Dive into the research topics of 'Annual review of transplant: kidney transplant 2012.'. Together they form a unique fingerprint.

Cite this